IRIS Accounts Production v25.1.3.33 04191347 Board of Directors 1.7.23 31.12.24 31.12.24 2.5.25 false true false false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041913472023-06-30041913472024-12-31041913472023-07-012024-12-31041913472022-06-30041913472022-07-012023-06-30041913472023-06-3004191347ns15:EnglandWales2023-07-012024-12-3104191347ns14:PoundSterling2023-07-012024-12-3104191347ns10:Director12023-07-012024-12-3104191347ns10:PrivateLimitedCompanyLtd2023-07-012024-12-3104191347ns10:SmallEntities2023-07-012024-12-3104191347ns10:Audited2023-07-012024-12-3104191347ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-12-3104191347ns10:SmallCompaniesRegimeForAccounts2023-07-012024-12-3104191347ns10:FullAccounts2023-07-012024-12-310419134712023-07-012024-12-3104191347ns10:OrdinaryShareClass12023-07-012024-12-3104191347ns10:Director22023-07-012024-12-3104191347ns10:RegisteredOffice2023-07-012024-12-3104191347ns5:CurrentFinancialInstruments2024-12-3104191347ns5:CurrentFinancialInstruments2023-06-3004191347ns5:ShareCapital2024-12-3104191347ns5:ShareCapital2023-06-3004191347ns5:SharePremium2024-12-3104191347ns5:SharePremium2023-06-3004191347ns5:RetainedEarningsAccumulatedLosses2024-12-3104191347ns5:RetainedEarningsAccumulatedLosses2023-06-3004191347ns5:NetGoodwill2023-07-012024-12-3104191347ns5:IntangibleAssetsOtherThanGoodwill2023-07-012024-12-3104191347ns5:ComputerSoftware2023-07-012024-12-3104191347ns5:LeaseholdImprovements2023-07-012024-12-3104191347ns5:PlantMachinery2023-07-012024-12-3104191347ns5:FurnitureFittings2023-07-012024-12-3104191347ns5:MotorVehicles2023-07-012024-12-3104191347ns5:ComputerEquipment2023-07-012024-12-3104191347ns5:NetGoodwill2023-06-3004191347ns5:ComputerSoftware2023-06-3004191347ns5:NetGoodwill2024-12-3104191347ns5:ComputerSoftware2024-12-3104191347ns5:NetGoodwill2023-06-3004191347ns5:ComputerSoftware2023-06-3004191347ns5:LeaseholdImprovements2023-06-3004191347ns5:PlantMachinery2023-06-3004191347ns5:FurnitureFittings2023-06-3004191347ns5:LeaseholdImprovements2024-12-3104191347ns5:PlantMachinery2024-12-3104191347ns5:FurnitureFittings2024-12-3104191347ns5:LeaseholdImprovements2023-06-3004191347ns5:PlantMachinery2023-06-3004191347ns5:FurnitureFittings2023-06-3004191347ns5:MotorVehicles2023-06-3004191347ns5:ComputerEquipment2023-06-3004191347ns5:MotorVehicles2024-12-3104191347ns5:ComputerEquipment2024-12-3104191347ns5:MotorVehicles2023-06-3004191347ns5:ComputerEquipment2023-06-3004191347ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104191347ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3004191347ns5:WithinOneYear2024-12-3104191347ns5:WithinOneYear2023-06-3004191347ns5:BetweenOneFiveYears2024-12-3104191347ns5:BetweenOneFiveYears2023-06-3004191347ns5:AllPeriods2024-12-3104191347ns5:AllPeriods2023-06-3004191347ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 04191347 (England and Wales)










Financial Statements

For The Period 1 July 2023 to 31 December 2024

for

Acc-Sel Genetics Limited

Acc-Sel Genetics Limited (Registered number: 04191347)






Contents of the Financial Statements
For The Period 1 July 2023 to 31 December 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Acc-Sel Genetics Limited

Company Information
For The Period 1 July 2023 to 31 December 2024







DIRECTORS: S G Winnington
G Florid





REGISTERED OFFICE: Goodridge Court
Goodridge Avenue
Gloucester
Gloucestershire
GL2 5EN





REGISTERED NUMBER: 04191347 (England and Wales)





AUDITORS: Kingscott Dix Limited
Chartered Accountants
and Statutory Auditor
Goodridge Court
Goodridge Avenue
Gloucester
Gloucestershire
GL2 5EN

Acc-Sel Genetics Limited (Registered number: 04191347)

Statement of Financial Position
31 December 2024

31.12.24 30.6.23
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 36,224 26,114
Tangible assets 5 268,965 372,070
305,189 398,184

CURRENT ASSETS
Stocks 675,098 664,198
Debtors 6 3,374,624 1,547,986
Cash at bank 800,463 810,297
4,850,185 3,022,481
CREDITORS
Amounts falling due within one year 7 4,034,277 2,757,453
NET CURRENT ASSETS 815,908 265,028
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,121,097

663,212

PROVISIONS FOR LIABILITIES 27,834 25,220
NET ASSETS 1,093,263 637,992

CAPITAL AND RESERVES
Called up share capital 9 100 100
Share premium 49,900 49,900
Retained earnings 1,043,263 587,992
SHAREHOLDERS' FUNDS 1,093,263 637,992

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 May 2025 and were signed on its behalf by:





G Florid - Director


Acc-Sel Genetics Limited (Registered number: 04191347)

Notes to the Financial Statements
For The Period 1 July 2023 to 31 December 2024

1. STATUTORY INFORMATION

Acc-Sel Genetics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The period represents an 18 month period to 31 December 2024. The company extended its year end to be consistent with the group.

Related party disclosure exemption
Intercompany transactions and balances with the holding company which are eliminated on consolidation have not been disclosed separately in these accounts in accordance with the exemption under paragraph 33.1A of the Financial Reporting Standard 102 applicable in the UK and Republic of Ireland'.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer . This is usually on delivery but on some occasions, the semen is stored for customers at the company's trading premises.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2021, is being amortised evenly over its estimated useful life of ten years.

During the period, the directors assessed the goodwill to be fully impaired on the basis the brand was no longer being used.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 100% on cost and 12.5% on cost
Plant and machinery - 33% on cost and 12.5% on cost
Office equipment, fixtures and fittings - 100% on cost, 20% on cost and 12.5% on cost
Motor vehicles - 25% on reducing balance
Computer equipment - 100% on cost, 33% on cost and 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Acc-Sel Genetics Limited (Registered number: 04191347)

Notes to the Financial Statements - continued
For The Period 1 July 2023 to 31 December 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership to another entity.

Basic financial liabilities
Basic financial liabilities, including trade and other creditors, and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year. If not, they are presented as creditors falling due after more than one year. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities
Financial liabilities are derecognised when, and only when, the company's obligations are discharged, cancelled, or they expire.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Acc-Sel Genetics Limited (Registered number: 04191347)

Notes to the Financial Statements - continued
For The Period 1 July 2023 to 31 December 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 52 (2023 - 42 ) .

4. INTANGIBLE FIXED ASSETS
Computer
Goodwill software Totals
£    £    £   
COST
At 1 July 2023 26,114 - 26,114
Additions - 41,265 41,265
Impairments (26,114 ) - (26,114 )
At 31 December 2024 - 41,265 41,265
AMORTISATION
Amortisation for period - 5,041 5,041
At 31 December 2024 - 5,041 5,041
NET BOOK VALUE
At 31 December 2024 - 36,224 36,224
At 30 June 2023 26,114 - 26,114

Acc-Sel Genetics Limited (Registered number: 04191347)

Notes to the Financial Statements - continued
For The Period 1 July 2023 to 31 December 2024

5. TANGIBLE FIXED ASSETS
Office
equipment,
Improvements fixtures
to Plant and and
property machinery fittings
£    £    £   
COST
At 1 July 2023 21,374 49,804 4,076
Additions - 10,100 -
Disposals - (3,019 ) -
At 31 December 2024 21,374 56,885 4,076
DEPRECIATION
At 1 July 2023 21,253 30,732 3,925
Charge for period 121 8,391 151
Eliminated on disposal - (2,209 ) -
At 31 December 2024 21,374 36,914 4,076
NET BOOK VALUE
At 31 December 2024 - 19,971 -
At 30 June 2023 121 19,072 151

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 July 2023 404,542 12,771 492,567
Additions 121,502 - 131,602
Disposals (110,756 ) (1,620 ) (115,395 )
At 31 December 2024 415,288 11,151 508,774
DEPRECIATION
At 1 July 2023 58,609 5,978 120,497
Charge for period 155,130 2,142 165,935
Eliminated on disposal (42,794 ) (1,620 ) (46,623 )
At 31 December 2024 170,945 6,500 239,809
NET BOOK VALUE
At 31 December 2024 244,343 4,651 268,965
At 30 June 2023 345,933 6,793 372,070

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 30.6.23
£    £   
Trade debtors 3,292,433 1,444,891
Other debtors 16,901 16,901
Tax - 60,671
Prepayments 65,290 25,523
3,374,624 1,547,986

Acc-Sel Genetics Limited (Registered number: 04191347)

Notes to the Financial Statements - continued
For The Period 1 July 2023 to 31 December 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 30.6.23
£    £   
Trade creditors 354,622 219,179
Amounts owed to group undertakings 2,653,772 2,124,270
Corporation tax 161,471 -
Social security and other taxes 418,202 136,891
Other creditors 14,167 20,864
Accrued expenses 432,043 256,249
4,034,277 2,757,453

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.12.24 30.6.23
£    £   
Within one year 238,448 104,135
Between one and five years 255,500 80,530
493,948 184,665

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 30.6.23
value: £    £   
100 Ordinary £1 100 100

10. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Peter Morgan (Senior Statutory Auditor)
for and on behalf of Kingscott Dix Limited

11. ULTIMATE PARENT UNDERTAKING AND CONSOLIDATED ACCOUNTS

The ultimate parent undertaking is Select Sires Inc, a company registered in USA. Consolidated group accounts can be obtained from that company at 5545 Avenida de los Robles, Visalia, California 93291, USA.